Literature DB >> 2508280

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.

E Kaminski1, J Hows, S Man, P Brookes, S Mackinnon, T Hughes, O Avakian, J M Goldman, J R Batchelor.   

Abstract

HLA "matched" unrelated donor bone marrow transplants are associated with an increased incidence and severity of graft-versus-host disease in comparison with HLA-identical sibling transplants. This is presumably due to HLA and non-HLA histocompatibility differences between donor and recipient. Using a limiting dilution assay, we have previously demonstrated a relationship between cytotoxic T lymphocyte precursor frequency and HLA disparity. In this study we have compared CTL-p frequencies with clinical GVHD, and demonstrate for the first time a significant correlation (P less than 0.005) between high CTL precursor frequency prior to BMT and severity of acute GVHD after HLA A, B, DR "matched" unrelated donor transplants using T cell depleted marrow. This assay system may be of value in the final selection of HLA "matched" unrelated donors for BMT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508280

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors.

Authors:  D Montagna; R Maccario; P Comoli; L Prete; M Zecca; E Giraldi; C Daielli; A Moretta; P De Stefano; F Locatelli
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

2.  Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

Authors:  J M Tiercy; C Morel; A C Freidel; F Zwahlen; L Gebuhrer; H Bétuel; M Jeannet; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 3.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. I: Normal primigravid and multiparous pregnancies.

Authors:  I T Manyonda; R S Pereira; J M Pearce; C E Sharrock
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 5.  Bone marrow transplantation using unrelated donors for haematological malignancies.

Authors:  O Ringdén
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

6.  Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.

Authors:  Ron Shapiro; Amit Basu; Henkie Tan; Edward Gray; Akhtar Kahn; Parmjeet Randhawa; Noriko Murase; Adriana Zeevi; Alin Girnita; Diana Metes; Roberta Ness; Debra C Bass; Anthony J Demetris; John J Fung; Amadeo Marcos; Thomas E Starzl
Journal:  J Am Coll Surg       Date:  2005-04       Impact factor: 6.113

7.  A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.

Authors:  L Sviland; A M Dickinson
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

8.  T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

Authors:  W M Smit; M Rijnbeek; C A van Bergen; W E Fibbe; R Willemze; J H Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. II: Recurrent spontaneous abortion and the effect of immunotherapy.

Authors:  I T Manyonda; R S Pereira; J M Pearce; C E Sharrock
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.

Authors:  B Kircher; K Lätzer; G Gastl; D Nachbaur
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.